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Defining the ability of simian virus 40 (SV40) to transform human cells has become of even greater importance with the
increased understanding that this virus may play a role in some human malignancies. This report documents the requirement
for viral small-t (ST) antigen in large-T (LT)-driven transformation of primary fibroblasts, a requirement that cannot be met by
a well-known oncogene, c-Ha-ras (EJ-ras), which can cooperate with LT in rodent systems. The cellular gene telomerase is
not essential for transformation, although transformed clones are not immortal without it. Similarly, an immortal mesothelial
cell line has been developed using LT and telomerase. Immortalized mesothelial cells are morphologically normal, but can
be transformed by introduction of ST, or ST  ras, but not by ras alone. It is likely that ST will be required along with LT for
transformation of most human cell types. © 2001 Academic Press
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INTRODUCTION
In the past decade, there has been a resurgence of
interest in simian virus 40 (SV40) as a possible human
tumor virus. The presence of SV40 is well documented in
pediatric brain tumors (Bergsagel et al., 1992; Lednicky
et al., 1995) and in mesothelioma (Carbone et al., 1994;
Rizzo et al., 2001). Evidence for an active role of the virus
is the strongest in mesothelioma, especially because it
has been possible to study infections of primary me-
sothelial cells in vitro (Bocchetta et al., 2000). Given
emerging evidence that SV40 may play a role in human
tumors, understanding the roles of SV40 gene products
in human cells becomes an important challenge. Histor-
ically, studies of SV40 infection of human cells have
focused on two outcomes—transformation and immor-
talization. Human cells are extremely difficult to immor-
talize (Klein et al., 1990; Shay et al., 1993; Shay and
Wright, 1989). SV40 increases the likelihood of immortal-
ization of diploid fibroblasts, extending the life span of
cells which ultimately undergo a crisis period from which
rare immortal clones emerge (Neufeld et al., 1987; Shay
and Wright, 1989; Shay et al., 1991). Transformation of
human cells by the SV40 early region is far more efficient,
especially when viral replication in semipermissive hu-
man cells is prevented by mutations in the viral replica-
tion origin or in T antigen (Small et al., 1982). It is possi-
ble to recover transformed foci or anchorage-indepen-
dent colonies at frequencies of greater than 0.1%, but
such transformants are not immortal (De Silva et al.,
1994; Klein et al., 1990; Reddel et al., 1988). The SV40
large-T (LT) antigen is required for the extension of life
span leading to immortalization and also for transforma-
tion. In contrast, small-t (ST) plays no known role in
immortalization, but plays an essential role in transfor-
mation of human fibroblasts (Chang et al., 1985; Porras et
al., 1996). A recent study indicated that tumorigenic con-
version of human cells could be achieved using three
defined genes—SV40 LT, the oncogene c-Ha ras (EJ-
ras), and hTERT, the catalytic subunit of the enzyme
telomerase (Hahn et al., 1999). Given the importance of
ST in SV40-induced transformation of human fibroblasts,
this suggested that either ras or hTERT might replace ST-
in LT-induced transformation. Surprisingly, neither ras,
hTERT, nor a combination of these genes was able to
substitute for ST to induce focus formation or anchorage-
independent growth. We further demonstrate that immor-
talization of human mesothelial cells could be achieved
using LT hTERT, but that subsequent transformation of
these established cells required the introduction of ST.
Thus, ST is essential for SV40 transformation of at least
these two human cell types.
RESULTS
SV40 transformation of human fibroblasts requires ST
antigen
To examine the requirements for both ST and LT in the
transformation of primary HDF cells, we transfected cells
with plasmids that expressed either LT alone or both LT
and ST antigens, under the control of replication-defec-
tive promoter/enhancer regions of SV40. LT-driven plas-
mid replication in semipermissive human fibroblasts is
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lethal to cells, and no foci were observed when WT
promoter regions were used in these experiments. As
shown in Fig. 1A, focus formation occurred very effi-
ciently when both SV40 proteins were introduced, and
this process was completely dependent on ST expres-
sion. Although not shown here, occasional foci were
picked and expanded and shown to express the appro-
priate viral proteins, LT and ST. Alternative variant pro-
teins were not found either in these pools or in cells
directly transfected with the starting plasmids.
The dependence on ST was found both for primary
cells (left two plates, Fig. 1A) and for HDF/TERT cells
(right half, Fig. 1A). HDF/TERT cells have been grown for
more than 200 generations and continuously express the
catalytic subunit of telomerase (data not shown). Thus,
immortalization of fibroblasts by telomerase did not elim-
inate the ST requirement for transformation.
Similar observations were made when transfected
cells were assayed for anchorage-independent growth
(Table 1). Both HDF cells (experiment 1) and HDF/TERT
cells (experiment 2) required ST for growth in a semisolid
medium. Cells were transfected with plasmids that ex-
pressed either LT and ST (Tt) or LT alone (T), then
collected 2 days after transfection for plating in 1.6–1.8%
methylcellulose (1.5  105 colonies per 60-mm dish).
Macroscopic colonies were easily visualized and
counted within 3–4 weeks. There were also many sub-
macroscopic, but sizable, colonies in cultures in which
both LT and ST were used. No colonies of over eight
cells in number were found in cells transfected with LT
alone. Based on counting macroscopic colonies, the
frequency of colony formation was 0.01–0.1% under the
conditions described. It is important to note that there
was no prior selection for transfected cells before mea-
surements of anchorage independence were made. In
other published studies, clones that expressed viral or
cellular oncogenes were first selected using coex-
pressed drug resistance markers before the efficiency of
growth in semisolid media was determined (Hahn et al.,
1999). This results in an apparently higher cloning effi-
ciency. Given that not all cells become stably transfected,
HDF cells show expected levels of anchorage indepen-
dence when plated within a few days of transfection.
Effect of EJ-Ras on SV40 transformation of HDF cells
A recent report on SV40 transformation of human cells
suggested that LT, EJ-ras, and hTERT were necessary
and sufficient to create human tumor cells (Hahn et al.,
1999) and raised the possibility to us that ras might
replace the requirement for ST in transformation. Accord-
ingly, we included a plasmid that expressed EJ-ras in our
experiments. The potency of the oncogenic ras ex-
pressed from this plasmid has been documented by
others (Cavender et al., 1995) and by focus formation in
transfected mouse 3T3 cells (Fig. 1C). As shown in Fig.
1B, oncogenic ras was unable to transform human fibro-
blasts and did not substitute for ST in focus formation
assays, even when hTERT was included as well. In all
combinations used, ST was required for focus formation
in HDF cells. Some of the foci formed in the presence of
EJ-ras grew more densely in some experiments, and this
can be seen in Fig. 1B as well.
To determine whether the ras oncogene played a more
important role in driving anchorage-independent growth
of transformed cells, transfected cells were plated in
methylcellulose and colony formation was scored. As
shown in Table 1, ras had little effect on the actual
numbers of colonies that grew from transfected HDF
cells (Experiment 1) or HDF/TERT cells (Experiment 2).
Colonies appeared somewhat more quickly when ras
was included in the transfection. However, the actual
number of colonies scored at 4 weeks was not signifi-
cantly different in the presence or absence of ras.
As predicted from studies of HDF/TERT fibroblasts, the
inclusion of a plasmid encoding hTERT with EJ-ras and
LT/ST plasmids did not enhance the efficiency of trans-
formation of primary fibroblasts to anchorage indepen-
dence. The reduction in colony number shown in Table 1
(Experiment 1) most likely reflects a lowered efficiency of
the three-plasmid transfection.
Establishment of human mesothelial cells
The infection of mesothelial cells by SV40 is distinctly
different from that of primary fibroblasts, in that a persis-
tent infection is established in which the genome is
episomally maintained and little cytopathic effect is ob-
served (Bocchetta et al., 2000). WT SV40-infected me-
sothelial cells became immortalized and formed focus-
like clones upon dilute plating. Infection with ST-defec-
tive viruses did not permit immortalization and outgrowth
of transformed clones (Bocchetta et al., 2000).
To further explore the role of ST in transformation of
these cells, we were interested in obtaining immortal-
ized, but nontransformed derivatives of mesothelial cells,
because the life span of these primary cells in culture is
even shorter than that of primary fibroblasts (fewer than
20 population doublings, while fibroblasts achieve 60–70
doublings). We began this study by introducing hTERT
through retroviral infection with pBABE-hygro-hTERT
(SV40 ori). Drug-resistant populations were readily ob-
tained, but within a few passages increasing numbers of
large, nondividing cells were observed. These resem-
bled senescent cells not only by their large cytoplasmic:
nuclear ratios but also by staining for -galactosidase at
pH 6 (data not shown). Because it seemed unlikely that
immortalization would be achieved with hTERT alone, we
infected some of the hygromycin-resistant pools of cells
with dl-888, an SV40 mutant virus that expressed LT but
not ST. As described earlier, the defect in ST expression
results from a splice donor mutation, and no truncated
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products of ST are observed in these infections (Porras
et al., 1996).
After infection with dl-888, cells were passaged using
1:3 split ratios each time they reached confluence. After
2 weeks in culture, cells appeared within the population
that resembled the original primary mesothelial cells and
showed little evidence of senescent morphology. For
example, these cells did not show -galactosidase ac-
tivity at pH 6 (data not shown). Several independent
pools of cells were derived following passage under
these conditions and have now grown for more than 60
generations, while the original primary cells senesced
after about 10 population doublings.
Immortalized pools were subsequently reinfected with
SV40 dl-888 (LT, ST) or with WT SV40 (LT, ST)
using a multiplicity of 5 pfu/cell. ME-T or ME-Tt cells were
derived from this second round of infection and were
maintained by passaging at 1:10 or greater split ratios.
As first reported by others (Bocchetta et al., 2000), ME-T
and ME-Tt cells maintained SV40 genomes in an episo-
mal state (data not shown) and shed low levels of virus
continuously. Between 104 and 105 pfu of virus has been
found in cell-free media at any given time and there was
no significant difference in virus yields of the two cell
populations, suggesting that ST plays little role in ge-
nome maintenance. The expected viral proteins, LT
alone or LT and ST, were expressed by these pools and
no other related products were found in Western blots
(data not shown).
Me-T cells did not show evidence of transformed mor-
phology and formed uniformly staining cell monolayers
at confluence. When ME-Tt cells were held at conflu-
ence, areas of “flat” foci emerged (Fig. 2A). In addition,
cells infected with WT virus, but not dl-888, acquired the
ability to grow in methylcellulose (Fig. 2B). Thus, the
continued expression of SV40 LT by these established
cultures was not sufficient to drive the morphologic
transformation of mesothelial cells, even after several
months in culture. However, reinfection with WT SV40
which encodes ST as well altered behaviors of the ME-T
cells.
To prove more directly that ST can drive this morpho-
logic transformation, ME-T cells were used for transfec-
tion experiments with pw2t, a plasmid that encodes ST
but not LT. The effect of ras in this system was also
tested. Two days after transfection, transfected cells
were collected by trypsinization, plated at 2  104 per
6-cm dish, grown for 2.5 weeks, and then stained. As
shown in Fig. 2C, several dense cell clusters appeared
on plates when cells were transfected with the ST plas-
mid. The ras oncogene alone did not increase the num-
bers of these morphologically altered areas, but en-
hanced the density of some of these clusters. The effi-
ciency of morphologic transformation of ME-T cells was
approximately the same as focus formation in fibroblasts
(see Fig. 1). Thus, morphologic transformation of estab-
lished mesothelial cells did not occur until ST was intro-
duced, and ST was sufficient to cause these alterations
in cells that already expressed LT.
DISCUSSION
SV40 transformation has been best studied in rodent
systems, in which ST rarely plays a role in focus forma-
tion, although it is often required for anchorage-indepen-
dent growth (Bouck et al., 1978). Primary human cells
showed an even greater resistance to oncogene-medi-
ated transformation, and SV40 LT alone was unable to
cause focus formation in primary fibroblasts or epithelial
FIG. 1. Dependence of focus formation on ST, in the presence and absence of TERT and EJ-ras. (A) HDF (left half of panel) and HDF/TERT cells
(right half of panel) were plated at 4 105 per 60-mm dish and then transfected with 2 g of each plasmid DNA in the presence of lipofectin. Duplicate
plates were used for each combination of plasmids, and each duplicate plate was split into four plates to allow foci to develop. Plasmids used
encoded LT and ST from a single plasmid (Tt) or LT only because of the dl-888 mutation (T). (B) HDF (left) or HDF/TERT cells (right) were transfected
with Tt (upper half) or T-only plasmid (bottom half) in the presence or absence of a second plasmid that encoded the oncogene EJ-ras (RAS). Plasmid
backbone DNA was used in transfections without EJ-ras. Foci were fixed in methanol and stained with methylene blue 4 weeks posttransfection. The
maximum efficiency of focus formation approached 1% in cells transfected with Tt-expressing plasmids. (C) 3T3 cells were plated at 4  105 cells
per 60-mm dish and then transfected with 2 g EJ-ras (RAS) or backbone plasmid control (RAS). Once cells reached confluence, they were
maintained in medium containing 1% serum and then stained when foci appeared between 2 and 3 weeks after transfection.
TABLE 1
Anchorage-Independent Growth of Transfected HDF and
HDF/TERT Cells
Plasmids transfected Colonies/60-mm dish  SD
Experiment 1a
Tt 66.6 13.7
T 0.0 0.0
Tt  ras 76.7 8.3
T  ras 0.0 0.0
Tt  ras  TERTb 35.0 1.0
T  ras  TERT 0.0 0.0
Experiment 2c
Tt 13.6 6.9
T 0.0 0.0
Tt  ras 17.3 3.3
T  ras 0.0 0.0
a Primary HDF cells were transfected with 2 g of each plasmid 2
days before plating in 1.6% methylcellulose.
b TERT was introduced using plasmid pBABE-hygro-TERT (SV40 ori-
defective).
c HDF/TERT cells were transfected with 2 g of each plasmid 2 days
before plating in 1.8% methylcellulose.
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cells. In contrast to the rodent systems, ST was also
required. In this study, we considered the possibility that
LT might be able to transform human cells in the pres-
ence of another oncogene, e.g., EJ-ras, as it can in rodent
systems (Cavender et al., 1995; Land et al., 1983). Fur-
thermore, because SV40-transformed fibroblasts are not
immortal and do not readily activate telomerase, we
tested whether the presence of active telomerase might
alter the transformation requirements of primary cells.
Our results strengthen the finding that ST plays a critical
role in the transformation of human fibroblasts and that
this requirement cannot be overcome by telomerase, the
ras oncogene, or both. In fact, the inclusion of these
important gene products had little effect on the overall
transformation efficiency, although telomerase was
clearly necessary for long-term growth of the trans-
formed cells. Foci produced in the presence of EJ-ras
appeared somewhat more robust, but ras had little effect
on the overall frequency of transformation.
The separation of transformation and immortalization
processes in human cells has long been known. Thus,
the absence of any requirement for hTERT in transfor-
mation was not surprising. Clearly, our studies address
only the basic elements required for transformation in
vitro. In the whole animal, growth of cells beyond the
normal senescence point is probably essential for tumor
formation and such an assay would be likely to show a
far greater dependence on the introduction of telomer-
ase or changes in other cellular activities that favor
immortalization.
The requirement for ST should be carefully explored in
other cell types, e.g., epithelial and endothelial cells in
which SV40 has been used as a transforming agent.
Because LT and ST are produced from a differentially
spliced primary transcript, many constructs initially de-
signed for studies of SV40 LT actually express both
proteins. Even in retroviral constructs where splicing can
occur before viral RNA is packaged, not all packaged
genomes have lost the LT intron but continue to express
both proteins in a subsequent round of infection. The
relatively poor understanding of ST itself and its minimal
role in rodent systems has led to a tendency to overlook
potential contributions of this viral gene product.
Of particular interest will be human cells from tissues
in which SV40 may play a role in tumor formation, one
example being mesothelial cells. A recent report has
FIG. 2. Transformed behaviors of ST-expressing ME-T cells. Mesothelial cells were established following the introduction of hTERT and LT as
described under Materials and Methods. Once immortalized, they were reinfected with either dl-888, giving rise to the ME-T cell population, or WT
SV40 to produce ME-Tt lines. (A) ME-T or ME-Tt cells were plated at 2  104 cells per 60-mm dish and then grown for 17 days before fixing and
staining. (B) 2  105 ME-T or ME-Tt cells were plated in 1.6% methylcellulose as described under Materials and Methods. No colonies were observed
in ME-T anchorage-independent cultures. Over 100 colonies were present in ME-Tt cultures, but the actual efficiency of plating is difficult to state
because cells aggregate within a day of plating, even in the gel-like media. These aggregated cells then increase to form visible colonies (ME-Tt)
or fail to thrive and eventually disintegrate (ME-T). (C) ME-T cells were transfected with a control plasmid (vector) or plasmids that express ST but
no LT antigen (t), EJ-ras (RAS), or a combination of ST and ras (t  RAS). Two days after transfection, cells were collected by trypsinization and 2 
104 cells from each transfection were plated and grown for 17 days before monolayers were fixed and stained to observe morphology.
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described a very unusual virus–host relationship be-
tween SV40 and primary mesothelial cells, one in which
the virus remains episomal and produces little if any
cytopathic effect. We have reproduced these findings
and confirmed that viral DNA is maintained episomally in
either the presence or absence of ST (data not shown).
Furthermore, we have been able to derive Me-T cells
which are immortalized by LT and hTERT. Despite the
ongoing expression of LT, the cells behave quite nor-
mally in culture, forming homogeneous monolayers of
cuboidal cells at confluence and failing to grow in semi-
solid media. When ST is introduced by reinfection with
WT SV40, growth properties of at least some of the cells
change dramatically, leading to densely packed flat foci
in confluent monolayers and to the growth of colonies of
cells in semisolid media. As was the case for primary
fibroblasts and HDF/TERT cells, the morphologic
changes in monolayer culture required the introduction
of ST and this requirement was not met by c-Ha-ras. The
ability of ST-expressing plasmids to induce such
changes will allow the study of mutant forms of ST as
well as experiments designed to examine specific ef-
fects of ST on cells that are necessary for transformation.
While the virus–host relationship of mesothelial cells
is significantly different from that of SV40 with human
fibroblasts, the continued need for ST antigen to alter the
behavior of mesothelial cells underscores the impor-
tance of both SV40 early proteins in the transformation of
human cell populations. In vitro experimental models are
lacking for other potential SV40 targets, notably cells
such as those in the choroid plexus, and such models
are greatly needed to support studies of SV40-associ-
ated tumors. Information gathered from approaches
used to explore the interaction of SV40 with mesothelial
cells may form the basis for future studies of other
potential target cells for SV40-related tumorigenesis.
MATERIALS AND METHODS
Cells
Primary human diploid fibroblasts (HDF) cells were
isolated from foreskins using collagenase and trypsin, as
described previously (Porras et al., 1996). Cells were
grown in Dulbecco’s modified Eagle’s medium (DME)
containing 10% fetal bovine serum (FBS). Immortal but
nontransformed HDF/TERT cells were derived by retro-
viral infection of HDFs with pBABE-hygro-TERT (SV40
ori-defective, see below). As described by others (Mo-
rales et al., 1999), immortal HDF/TERT cells retain normal
characteristics, do not form foci or clone in agar, and
maintain normal ploidy by FACS analyses (data not
shown). Primary mesothelial cells were the kind gift of
Dr. Michele Carbone and were grown as described (Boc-
chetta et al., 2000) using DME  20% FBS. When cells
reached confluence, they were subcultured 1:2 or 1:3.
Cells were infected with the SV40 ori retrovirus pBABE-
hygro-TERT, then grown in 30 g/ml hygromycin during
subsequent subculturing. After 2 weeks of selection,
cells were infected with 5  105 plaque-forming units
(pfu) SV40 dl-888, a multiplicity of approximately 5 pfu/
cell. Once cells became established in culture following
hTERT and LT expression, they were maintained in
DME  10% FBS.
Plasmids
The plasmids used for LT and ST expression were
described previously (Phillips and Rundell, 1988; Porras
et al., 1996). The plasmid oripw2 (Tt plasmid) encodes
both early proteins under the control of replication-de-
fective SV40 promoter-enhancer regions. Plasmid
oripw2DL (T only) contains a deletion of the ST splice
donor, a mutation derived from the virus dl-888, and
encodes no ST fragment proteins at all. Plasmid oripw2t
encodes only ST and carries a 1-kb deletion of se-
quences unique to LT (SV40 nucleotides 2666–3733).
The pBABE-puro and pBABE-hygro derivatives used to
produce hTERT retroviruses were the kind gift of Dr.
Robert Weinberg (Hahn et al., 1999) and were modified
by replacing the SV40 promoter region that drives anti-
biotic resistance with the origin-defective sequences
used in plasmids Tt and T. pBABE-hygro-hTERT (SV40
ori) was used in this study. Retroviruses were grown in
Phoenix cells, using procedures described at http://
www.stanford.edu/group/nolan/index.html. A plasmid
that expresses EJ-ras under the control of its own
promoter was obtained from Dr. M. Judith Tevethia
(Cavender et al., 1995).
Transfection
Cells were plated at 4  105 cells per 60-mm dish the
day before transfection. Transfections were done using
2–6 g total plasmid DNA and 20 l lipofectin (GibcoBRL
Life Technologies, Inc.), according to the manufacturer’s
specifications. Briefly, DNA–lipofectin complexes were
added to cells for 5 h, and then an equal volume of
medium containing 20% FBS was added overnight. The
following morning, medium and transfection reagents
were removed from cells and replaced with DME  10%
FBS.
Focus formation
HDF and HDF/TERT focus formation assays were
done as previously described (Porras et al., 1996). Trans-
fections were done in duplicate, and then each trans-
fected plate was split into four plates 2 days after trans-
fections. Mesothelial ME-T and ME-Tt cells were plated
at 2 104 per 60-mm dish, grown for 17 days in standard
medium containing 10% FBS, and then fixed and stained.
Foci were visualized by fixation with methanol and stain-
ing with methylene blue.
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Growth in methylcellulose
Transfected cells from several dishes were trypsinized
and pooled for plating in 1.6–1.8% methylcellulose in
DME containing 10% FBS. Bacterial 60-mm petri dishes
were first coated with 1% agarose by pipetting agarose
into the plates and then immediately removing it. An 8-ml
layer of methylcellulose was then pipetted onto the aga-
rose-coated plates. Medium (0.4 ml) containing the cells
was then added to each plate and gently stirred to
distribute the cells. For HDF and HDF/TERT cells, dupli-
cate 6-cm plates were transfected for each experimental
condition, and each duplicate was independently sub-
cultured into three methylcellulose plates. All six plates
were combined to determine standard deviations. For
mesothelial cells, a minimum of 1.5  105 cells were
plated for optimum efficiency of colony formation. Colo-
nies were counted 3–4 weeks after plating. Experiments
shown are representative of at least three replicate ex-
periments.
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